An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here
Innovation is the lifeblood...
Professor Tomáš Hanke of the Jenner Institute, University of Oxford discusses why the development of HIV-1 vaccine remains a high global health priority
Since the...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders